Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGM.L Regulatory News (AGM)

  • There is currently no data for AGM

AGM Statement

18 Dec 2018 07:00

RNS Number : 7418K
Applied Graphene Materials PLC
18 December 2018
 

18 December 2018

 

Applied Graphene Materials plc

 

("Applied Graphene Materials", "the Group" or "the Company")

 

Annual General Meeting Statement

 

Key milestone achieved with James Briggs Ltd order

 

Applied Graphene Materials, the producer of specialty graphene materials, will be holding its Annual General Meeting at 11.00am today at The Farndale Suite, The Wilton Centre, Redcar, Cleveland, TS10 4RF, during which the Chairman, Bryan Dobson, will make the following statement: 

"The Board continues to focus on the commercialisation of its products and proprietary technologies via its numerous active engagements and has made good progress in recent months.

I am pleased to report that we have recently achieved a key milestone, having fulfilled the scale-up production purchase order from James Briggs Ltd (JBL) in preparation for full product launch. JBL has successfully completed its first production batch which is a significant milestone for commercial realisation. Extensive testing has demonstrated repeated and outstanding improvements in anti-corrosion performance for JBL's automotive aerosol primer. JBL plans to launch their new range of graphene enhanced anti-corrosion aerosols under their Hycote brand.

We were also pleased to participate in the opening of the UK's Graphene Engineering and Innovation Centre (GEIC) in Manchester last week. Meeting with multiple participants, the opportunities for graphene technology remain buoyant. Finding practical application solutions for the challenges surrounding the exploitation of graphene nanoplatelet technology is the key focus of AGM's strategy for commercial progress and this is wholly complementary to the objectives of GEIC. We look forward to working closely with GEIC in the months ahead in the further development of world-class application solutions. 

We have had significant changes on the Executive team in the last few months and Adrian and David have both settled into their new roles very quickly as Chief Executive and Chief Financial Officer. Their absolute focus is to increase the commercial momentum and to grow the business and revenues.

The Group continues to be well funded as it seeks to capitalise on the ever maturing pipeline of opportunities."

 

For further information, please contact:

 

Applied Graphene Materials +44 (0) 1642 438 214

Adrian Potts, Chief Executive Officer

David Blain, Chief Financial Officer

 

N+1 Singer +44 (0) 207 496 3000

Richard Lindley / Justin McKeegan

 

Hudson Sandler +44 (0) 207 796 4133

Charlie Jack / Emily Dillon

Notes to Editors

Applied Graphene Materials works in partnership with its customers using its knowledge and expertise to provide bespoke graphene dispersions and formats to deliver enhancements and benefits for a wide range of applications. The Group's strategy is to target commercial applications in three core markets: coatings, composites and functional materials. 

The Group has developed proprietary bottom-up processes which are capable of producing high purity graphene nanoplatelets using a continuous process. The manufacturing process is based on sustainable, readily available raw materials and therefore does not rely on the supply of graphite, unlike a number of other graphene production techniques. Applied Graphene Materials owns the intellectual property and know-how behind this process.

Applied Graphene Materials was founded by Professor Karl Coleman in 2010 with its operations and processes based on technology that he initially developed at Durham University. The Group was admitted to AIM in November 2013, raising £11 million, and is based at the Wilton Site on Teesside. In January 2016 the Group raised £8.5m to support its ongoing activities and in October 2017 the Group raised a further £9.8m.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMEAKAXFSKPFFF
Date   Source Headline
17th Dec 20197:00 amRNSAGM Statement
30th Oct 20193:48 pmRNSDirector/PDMR Shareholding (correction)
30th Oct 20192:02 pmRNSDirector/PDMR Shareholding
30th Oct 20197:00 amRNSCustomer product launched via leading UK retailer
21st Oct 20193:30 pmRNSAGM presents to investors in Beijing
16th Oct 20197:00 amRNSAnnual Results
9th Oct 20192:00 pmRNSOperational update
3rd Oct 20197:00 amRNSAGM develops composite applications for space
30th Sep 201911:30 amRNSNotice of Annual Results
10th Sep 201912:00 pmRNSAGM to present at technical & investor conferences
5th Aug 20194:41 pmRNSSecond Price Monitoring Extn
5th Aug 20194:36 pmRNSPrice Monitoring Extension
5th Aug 20192:05 pmRNSSecond Price Monitoring Extn
5th Aug 20192:00 pmRNSPrice Monitoring Extension
31st Jul 20197:00 amRNSIssue of share options to Directors
10th Jul 20197:00 amRNSAGM advances applications for water-based coatings
9th Jul 201912:20 pmRNSNew Coatings Product Launch
3rd Jun 20197:00 amRNSAGM sign distribution agreement with Carst&Walker
30th May 20197:00 amRNSAGM to showcase Aerospace composites at NATEP
23rd May 20199:37 amRNSAGM signs distribution agreement with CAME Srl
17th May 20197:00 amRNSAGM secures patent in strategic territory
3rd Apr 20197:00 amRNSInterim Results
21st Mar 20197:00 amRNSAGM to attend Corrosion 2019 Conference & Expo
21st Mar 20197:00 amRNSNotice of Interim Results
14th Mar 20197:24 amRNSAGM to Present at European Coatings Show
7th Mar 201911:05 amRNSSecond Price Monitoring Extn
7th Mar 201911:00 amRNSPrice Monitoring Extension
6th Mar 201910:34 amRNSAppointment to the NGA's Industry Council
28th Feb 201911:43 amRNSBreakthrough anti-corrosion graphene technology
31st Jan 20194:58 pmRNSIssue of share options to Directors
21st Jan 201912:00 pmRNSDirector/PDMR Shareholding
15th Jan 20192:05 pmRNSSecond Price Monitoring Extn
15th Jan 20192:00 pmRNSPrice Monitoring Extension
10th Jan 201912:26 pmRNSHolding(s) in Company
18th Dec 20184:33 pmRNSResult of AGM
18th Dec 20187:00 amRNSAGM Statement
13th Dec 20182:05 pmRNSSecond Price Monitoring Extn
13th Dec 20182:00 pmRNSPrice Monitoring Extension
18th Oct 20187:00 amRNSFinal Results
9th Oct 20188:23 amRNSBoard Appointment
12th Sep 20184:40 pmRNSSecond Price Monitoring Extn
12th Sep 20184:35 pmRNSPrice Monitoring Extension
12th Sep 20182:05 pmRNSSecond Price Monitoring Extn
12th Sep 20182:00 pmRNSPrice Monitoring Extension
28th Aug 20182:17 pmRNSNotice of Annual Results
1st Aug 20187:00 amRNSBoard Change
29th Jun 201810:19 amRNSBoard Changes
22nd May 20184:40 pmRNSSecond Price Monitoring Extn
22nd May 20184:35 pmRNSPrice Monitoring Extension
22nd May 20187:00 amRNSJames Briggs Commercial Agreement & Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.